WallStreetZenWallStreetZen

NASDAQ: LRMR
Larimar Therapeutics Inc Stock

$11.74-0.65 (-5.25%)
Updated Feb 27, 2024
LRMR Price
$11.74
Fair Value Price
$0.83
Market Cap
$515.46M
52 Week Low
$2.18
52 Week High
$13.68
P/E
-19.57x
P/B
5.56x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$33.38M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.12
Operating Cash Flow
-$31M
Beta
0.64
Next Earnings
Mar 12, 2024
Ex-Dividend
N/A
Next Dividend
N/A

LRMR Overview

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LRMR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LRMR ($11.74) is overvalued by 1,312.14% relative to our estimate of its Fair Value price of $0.83 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
LRMR ($11.74) is not significantly undervalued (1,312.14%) relative to our estimate of its Fair Value price of $0.83 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
LRMR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more LRMR due diligence checks available for Premium users.

Be the first to know about important LRMR news, forecast changes, insider trades & much more!

LRMR News

Valuation

LRMR fair value

Fair Value of LRMR stock based on Discounted Cash Flow (DCF)
Price
$11.74
Fair Value
$0.83
Overvalued by
1,312.14%
LRMR ($11.74) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LRMR ($11.74) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
LRMR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

LRMR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-19.57x
Industry
14.95x
Market
36.02x

LRMR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.56x
Industry
6.23x
LRMR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

LRMR's financial health

Profit margin

Revenue
$0.0
Net Income
-$9.1M
Profit Margin
0%
LRMR's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$104.0M
Liabilities
$11.2M
Debt to equity
0.12
LRMR's short-term assets ($98.48M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LRMR's short-term assets ($98.48M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LRMR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LRMR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.2M
Investing
-$46.4M
Financing
$30.0k
LRMR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

LRMR vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
LRMR$515.46M-5.25%-19.57x5.56x
CDMO$515.40M+1.24%-47.94x2.81x
MRSN$514.89M+5.17%-2.41x9.86x
LIAN$520.32M+0.10%-5.94x2.57x
ATXS$507.42M-0.92%-6.59x2.75x

Larimar Therapeutics Stock FAQ

What is Larimar Therapeutics's quote symbol?

(NASDAQ: LRMR) Larimar Therapeutics trades on the NASDAQ under the ticker symbol LRMR. Larimar Therapeutics stock quotes can also be displayed as NASDAQ: LRMR.

If you're new to stock investing, here's how to buy Larimar Therapeutics stock.

What is the 52 week high and low for Larimar Therapeutics (NASDAQ: LRMR)?

(NASDAQ: LRMR) Larimar Therapeutics's 52-week high was $13.68, and its 52-week low was $2.18. It is currently -14.18% from its 52-week high and 438.53% from its 52-week low.

How much is Larimar Therapeutics stock worth today?

(NASDAQ: LRMR) Larimar Therapeutics currently has 43,905,903 outstanding shares. With Larimar Therapeutics stock trading at $11.74 per share, the total value of Larimar Therapeutics stock (market capitalization) is $515.46M.

Larimar Therapeutics stock was originally listed at a price of $237.00 in Jun 19, 2014. If you had invested in Larimar Therapeutics stock at $237.00, your return over the last 9 years would have been -95.05%, for an annualized return of -28.39% (not including any dividends or dividend reinvestments).

How much is Larimar Therapeutics's stock price per share?

(NASDAQ: LRMR) Larimar Therapeutics stock price per share is $11.74 today (as of Feb 27, 2024).

What is Larimar Therapeutics's Market Cap?

(NASDAQ: LRMR) Larimar Therapeutics's market cap is $515.46M, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Larimar Therapeutics's market cap is calculated by multiplying LRMR's current stock price of $11.74 by LRMR's total outstanding shares of 43,905,903.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.